Grafa News and Videos — Page 1120

Aeluma (NASDAQ:ALMU), a pioneer in the development of high-performance optoelectronic devices, announced on April 13, 2026, that it has been awarded more than $4 million in new U.S. government contracts.

Perella Weinberg Partners (NASDAQ:PWP) has entered into a definitive agreement to acquire Gleacher Shacklock, a prominent London-based independent advisory firm.

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $259.2 billion as of March 31, 2026.

Eli Lilly and Company (NYSE:LLY) announced Monday that its Phase 3 BRUIN CLL-322 trial achieved its primary endpoint, demonstrating that the addition of Jaypirca (pirtobrutinib) to a standard regimen of venetoclax and rituximab significantly extended the time patients lived without their disease worsening.

Somnigroup International (NYSE:SGI) reached an agreement to acquire Leggett & Platt (NYSE:LEG) in an all-stock transaction valued at approximately $2.5 billion, a move that unites the world's largest bedding brand owner with its primary component supplier.

Fastenal (NASDAQ:FAST), a global leader in the wholesale distribution of industrial and construction supplies, reported its financial results for the first quarter ended March 31, 2026, today.

Vertiv Holdings (NYSE:VRT), a global provider of critical digital infrastructure and continuity solutions, announced on April 13, 2026, the acquisition of BMarko Structures.

Regeneron Pharmaceuticals (NASDAQ:REGN) and Telix Pharmaceuticals (NASDAQ:TLX) announced a landmark strategic collaboration on April 13, 2026, to co-develop and co-commercialize next-generation radiopharmaceutical therapies (RPTs).

Hillman Solutions (NASDAQ:HLMN), a leading provider of hardware products and merchandising solutions, announced on April 13, 2026, the acquisition of Delaney Hardware.

Allogene Therapeutics (NASDAQ:ALLO), a pioneer in allogeneic "off-the-shelf" CAR-T cell therapy, announced promising interim futility results today from its randomized Phase 2 ALPHA3 trial.